Wilex Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Munich Germany (1997)
Status: Acquired by Heidelberg Pharma AG (2010)

Organization Overview

First Clinical Trial
2004
NCT00083525
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree